Prevention of pulmonary fibrosis via trichostatin A (TSA) in bleomycin induced rats

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 31, Issue 3, 2014, Pages 219-226

  Ye, Qing ^a   Li, Yanqin ^a   Jiang, Handong ^a   Xiong, Jianfei ^a   Xu, Jiabo ^a   Qin, Hui ^a   Liu, Bin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hdaci; P smad2; Pulmonary fibrosis

Indexed keywords

BLEOMYCIN; DIMETHYL SULFOXIDE; EOSIN; HEMATOXYLIN; HISTONE DEACETYLASE 2; MESSENGER RNA; PLASMA PROTEIN; SMAD2 PROTEIN; TRICHOSTATIN A; HDAC2 PROTEIN, RAT; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; SMAD2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; IN VIVO STUDY; LUNG PARENCHYMA; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; REAL TIME POLYMERASE CHAIN REACTION; STAINING; TREATMENT INDICATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL PROTECTION; CHEMICALLY INDUCED; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LUNG; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TIME FACTOR;

ANIMALS; BLEOMYCIN; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACIDS; LUNG; MALE; PHOSPHORYLATION; PULMONARY FIBROSIS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TIME FACTORS;

EID: 84929614044     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Toby M. Maher, Athol U. Wells Lost in translation; from animal models of pulmonary fibrosis to human disease. Respirology, 2009, 14: 915-916.
2. Roth S Y, Denu J M, Allis C D. Histone Acetyltranferases[ J].Annu Rev Biochem, 2001, 70: 81-120.
3. Minucci S, Pelicci P G. Histone deacetylase inhibitors and the promise of epigenetic(and more)treatments for cancer[J]. Nat Rev Cancer, 2006, 6(1): 38-51.
4. Jing Xia, Binghong Feng.The research progress of histone deacetylase. Journal of Guangdong Pharmaceutical Colleg, Oct, 2010, 26(5): 546-551.
5. Maoyin Pang, Shougang Zhuang. Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders. The Journal Of Pharmacology And Experimental Therapeutics. 335:266-272, 2010.
6. Toews GB, White ES, et al.Mechanisms of pulmonary fibrosis. Annu Rev Med 2004;55:395-417.
7. Jen CW, Chin Chen et al. Enhanced histone deacetylase enzyme activity in primary myelofibrosis. Leukemia & Lymphoma, December 2008; 49(12): 2321-2327.
8. Hossein Hemmatazad, Hanna Maciejewska Rodrigues et al.Histone Deacetylase 7, a Potential Target for the Antifibrotic Treatment of Systemic Sclerosis. Arthritis & Rheumatism.May 2009, 60(5) 1519-1529.
9. Abishek Iyer, Andrew Fenning et al. Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats. British Journal of Pharmacology (2010), 159, 1408-1417.
10. Qing JZ, Ling LY et al. TGFb Mediated Transition of Corneal Fibroblasts From a Proinflammatory State to a Profibrotic State Through Modulation of Histone Acetylation. J. Cell. Physiol. 224: 135-143, 2010.
11. Gregoretfi I V, Lee Y M, Goodson H V. Molecular evolution of the histone deacetylase family: functional implications of phylogenetie analysis [ J]. J Mol Biol, 2004, 338(1): 17-31.
12. Itoh S, Itoh F, Goumans MJ, et al. Signaling of TGFβfamily members through Smad proteins [J]. Eur J Biochem, 2000, 267(24): 6954-6967.
13. Pasche B. Role of TFG-β in cancer[J]. J Cell Physiol, 2001, 186(2): 153-168.
14. Ulrika Zagai, Elham Dadfar, Joachim Lundahl, et al. Eosinophil Carlonic Protein Stimulates.
15. Huijun Duan et al. Expression of p-Smad2 3. Smad7 in experimental renal interstitial fibrosis in rats model. Basic and clinical medicin. August 2006.1(26).871-876.
16. Weichao Guo, Bin Shan, Ross C. Klingsberg. Abrogation of TGF- induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Am J Physiol Lung Cell Mol Physiol 297: L864-L870, 2009.
17. Weiwei Lei, Kehua Zhang et al. Histone deacetylase 1 is required for transforming growth factor-β1-induced epithelial-mesenchymal transition. The International Journal of Biochemistry & Cell Biology 42 (2010) 1489-1497.